博晖创新:获生殖道病原体五项核酸检测试剂盒注册证

Core Viewpoint - The company, Bohui Innovation, has recently received a medical device registration certificate from the National Medical Products Administration of China for its reproductive tract pathogen nucleic acid detection kit, enhancing its product offerings and competitive edge, although sales remain uncertain [1] Group 1: Product Details - The product is a five-pathogen nucleic acid detection kit (PCR - fluorescence probe method) classified as Class III medical device [1] - The registration number is 国械注准 20263400155, with a validity period from January 23, 2026, to January 22, 2031 [1] Group 2: Market Implications - The certification enriches the company's product variety, potentially improving its market competitiveness [1] - However, there is uncertainty regarding the sales performance of the newly certified product [1]

Bohui Innovation-博晖创新:获生殖道病原体五项核酸检测试剂盒注册证 - Reportify